Patents expiring in 2034

US 8846643

Phosphonates with reduced toxicity for treatment of viral infections

The Regents of the University of California · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8846605

Formulations and methods of use for alpha connexin C-terminal (ACT) peptides

FIRSTRING RESEARCH, INC. · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8846102

Non-viral compositions and methods for transfecting gut cells in vivo

ENGENE, INC. · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8846055

Virulence determinant within the E2 structural glycoprotein of classical swine fever virus

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8846866

Aldehyde tags, uses thereof in site-specific protein modification

The Regents of the University of California · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8846649

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8846908

Tricyclic carbamate JAK inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8846859

Compositions and methods of use of targeting peptides against placenta and adipose tissues

The Board of Regents of the University of Texas System · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8846753

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8846697

Purine analogs

The Regents of the University of California · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8852936

Autologous lymph node transfer in combination with VEGF-C or VEGF-D growth factor therapy to treat lymphedema and to improve reconstructive surgery

Laurantis Pharma Oy · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8853427

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8853247

Oligomer-nitroimidazole anti-infective conjugates

Nektar Therapeutics · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8853215

Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes

Takeda Pharmaceutical Company Limited · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8852605

Vibrio cholerae O139 conjugate vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8853152

Pharmaceutical compositions

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8853151

Pro-drug complexes and related methods of use

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8852626

Controlled-release CNS modulating compositions and methods for the treatment of otic disorders

The Regents of the University of California · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8853160

GLP-1, exendin-4, peptide analogs and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8853205

Heteropyrrole analogs acting on cannabinoid receptors

UNIVERSITY OF CONNECTICUT · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8853217

Compounds useful as inhibitors of ATR kinase

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8853228

Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase

UNIVERSITY OF CONNECTICUT · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8853244

Thiophene-carboxamides useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8853255

3-phenoxymethylpyrrolidine compounds

Theravance Biopharma R&D IP, LLC · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8853254

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8853271

Method for inhibiting activity and/or expression of matrix metalloproteinase, inhibiting phosphorylation of mitogen-activated protein kinase, and/or promoting expression of collagen using tormentic acid

China Medical University · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8853252

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

Jenrin Discovery, LLC · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8853277

Nitroxide therapy for the treatment of von Hippel—Lindau disease (VHL) and renal clear cell carcinoma (RCC)

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8853356

Use of pentagastrin to inhibit gastric acid secretion or as a diuretic

The Regents of the University of California · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8853415

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8853397

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8852447

Porous nanostructures and methods involving the same

The Regents of the University of California · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8852568

Compositions and methods for treating and preventing skeletal muscle deficiencies

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8852576

Modified sodium iodide symporter proteins and uses thereof

China Medical University · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8852598

Puumala virus full-length M segment-based DNA vaccines

The United States of America as represented by the Secretary of the Army · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8852151

Swallowable drug delivery device and method of delivery

Rani Therapeutics, LLC · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8852940

Embryonic stem cell specific microRNAs promote induced pluripotency

The Regents of the University of California · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8853325

Water-soluble polymer alkanals

Nektar Therapeutics · Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2908706

TRAITEMENTS UTILISANT L'ESLICARBAZEPINE ET L'ACETATE D'ESLICARBAZEPINE

BIAL PORTELA & CA SA [PT] · Granted Thu Oct 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2905273

RENFORCATEURS D'HYDROSOLUBILITE A BASE DE GLYCOGENE

ACRAF [IT] · Granted Thu Oct 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2014163518

TRAITEMENTS UTILISANT L'ESLICARBAZÉPINE ET L'ACÉTATE D'ESLICARBAZÉPINE

BIAL PORTELA & Cª S A [PT] · Granted Thu Oct 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8859750

RNAi modulation of RSV and therapeutic uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8859736

Monoclonal antibodies that inhibit the wnt signaling pathway and methods of production and use thereof

The Board of Regents of the University of Oklahoma · Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8859527

Inclusion complex of deoxypodophyllotoxin of cyclodextrin, preparation method, use for treatment of cancer thereof

CHINA PHARMACEUTICAL UNIVERSITY · Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8858950

Delivery of pharmaceutical agents via the human insulin receptor

The Regents of the University of California · Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8858959

Gel vaccine delivery system for treating poultry

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8859207

Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8859284

Delivery of nanoparticles to neurons

United States of America as represented by the Secretary of the Air Force · Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)